Title: Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial
Authors: Hristova, Ivalina ×
Boellaard, Ronald
Vogel, Wouter
Mottaghy, Felix
Marreaud, Sandrine
Collette, Sandra
Schöffski, Patrick
Sanfilippo, Roberta
Dewji, Raz
van der Graaf, Winette
Oyen, Wim #
Issue Date: May-2015
Series Title: European Journal of Nuclear Medicine and Molecular Imaging vol:42 issue:6 pages:848-857
Abstract: (18)F-Labelled fluorodeoxyglucose (FDG) can detect early changes in tumour metabolism and may be a useful quantitative imaging biomarker (QIB) for prediction of disease stabilization, response and duration of progression-free survival (PFS). Standardization of imaging procedures is a prerequisite, especially in multicentre clinical trials. In this study we reviewed the quality of FDG scans and compliance with the imaging guideline (IG) in a phase III clinical trial.
ISSN: 1619-7070
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Experimental Oncology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072_VEG110727_Eur J Nucl Med Mol Imaging.pdf Published 657KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science